These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9803727)

  • 1. The effectiveness of combined saquinavir and ketoconazole treatment in reducing HIV viral load.
    Jordan WC
    J Natl Med Assoc; 1998 Oct; 90(10):622-4. PubMed ID: 9803727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients.
    Autar RS; Wit FW; Sankote J; Sutthichom D; Kimenai E; Hassink E; Hill A; Cooper DA; Phanuphak P; Lange JM; Burger DM; Ruxrungtham K
    AIDS; 2007 Jul; 21(12):1535-9. PubMed ID: 17630547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
    Reiser M; Salzberger B; Stiepel A; Hoetelmans R; Diehl V; Fätkenheuer G
    Eur J Med Res; 1999 Feb; 4(2):54-8. PubMed ID: 10066640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoconazole may improve PI penetration.
    AIDS Patient Care STDS; 1999 Dec; 13(12):753. PubMed ID: 10743541
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
    Lallemand F; Adda N; Schneider V; Jacomet C; Salhi Y; Rozenbaum W
    Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672
    [No Abstract]   [Full Text] [Related]  

  • 6. The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients.
    Grub S; Bryson H; Goggin T; Lüdin E; Jorga K
    Eur J Clin Pharmacol; 2001 May; 57(2):115-21. PubMed ID: 11417442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saquinavir plus ritonavir reduce viral load by 99.9 percent.
    Vazquez E
    Posit Aware; 1996; 7(6):8-9. PubMed ID: 11363983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saquinavir. Clinical pharmacology and efficacy.
    Vella S; Floridia M
    Clin Pharmacokinet; 1998 Mar; 34(3):189-201. PubMed ID: 9533981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV agents. A protease-only regimen--Kaletra and saquinavir.
    TreatmentUpdate; 2004; 16(3):8. PubMed ID: 17216837
    [No Abstract]   [Full Text] [Related]  

  • 10. Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients.
    Michelet C; Ruffault A; Sébille V; Arvieux C; Jaccard P; Raffi F; Bazin C; Chapplain JM; Chauvin JP; Dohin E; Cartier F; Bellissant E
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3393-402. PubMed ID: 11709314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of two protease inhibitors reduces HIV viral load by 99.9%.
    AIDS Patient Care STDS; 1996 Dec; 10(6):375. PubMed ID: 11361557
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined protease results continue to hold up.
    McGuire S
    Posit Aware; 1997; 8(1):15. PubMed ID: 11364089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor].
    Mouroux M; Bossi P; Yvon-Groussin A; Delaugerre C; Valantin MA; Tubiana R; Coutellier A; Bonmarchand M; Bricaire F; Katlama C; Agut H; Huraux JM; Calvez V
    Pathol Biol (Paris); 1999 May; 47(5):549-52. PubMed ID: 10418038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
    TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic drug monitoring of saquinavir in patients during protease inhibitor therapy with saquinavir alone or in combination with ritonavir or nelfinavir.
    Langmann P; Zilly M; Weissbrich B; Schlör C; Väth T; Richter E; Klinker H
    Eur J Med Res; 2000 Feb; 5(2):59-62. PubMed ID: 10720564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Good experiences with saquinavir. Double boosting of protease inhibitors gains significance].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():44. PubMed ID: 15373047
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus.
    Khaliq Y; Gallicano K; Venance S; Kravcik S; Cameron DW
    Clin Pharmacol Ther; 2000 Dec; 68(6):637-46. PubMed ID: 11180024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saquinavir: major study shows survival benefit in treatment-naive patients.
    James JS
    AIDS Treat News; 1997 Jul; (No 274):6. PubMed ID: 11364463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The choice of HIV protease inhibitor: indinavir is currently the best option.
    Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saquinavir in the management of HIV infection.
    Moyle G
    Br J Hosp Med; 1997 Jun 4-17; 57(11):560-4. PubMed ID: 9307673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.